API
![Te parakore o te konupora (R)-[(3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino]phenylacetate i te utu pai](https://ecdn6.globalso.com/upload/p/689/image_product/2024-04/661cf240b167b43209.png)
Kaihanga parakore teitei CAS 1197-18-8 Waikawa Tranexamic
Ko te waikawa tranexamic, e kiia ana ko te waikawa tranexamic, he whakaputanga waihanga o te lysine he rite te hanganga ki te tyrosine. I whakamanahia e nga whakamatautau haumanu, he pai mo nga momo kiri katoa, ka taea te tango i te kiri, te ma, me te whakamarama i nga waahi, penei i te: te paheketanga i muri i te ra o te ra, nga wahi pouri (chloasma, freckles, senile lentils, etc.), kiri tairongo, hakihaki. me te mumura, te tiaki i muri i te mahi i muri i te taiaho, te maimoatanga marama puhoi, me etahi atu.
Ko te waikawa tranexamic he rongoa antifibrinolytic waikawa amino waihanga ka taea te aukati i te herenga o te lysine i roto i te fibrin ki te plasmin, na reira ka aukati i te lysis o nga kopa fibrin me te whakaputa hemostasis. Kei te nuinga whakamahia te reira haumanu. Mo nga momo momo whakaheke toto na te hyperfibrinolysis.
Nga tono waikawa tranexamic
1. Ko te waikawa tranexamic he rongoa anti-fibrinolytic, ka taea e ia te rongoa i nga momo toto whakapeka me te mau tonu me te whakatutuki i te hemostasis.
2.Ka taea e te waikawa Tranexamic te whakaheke i te hanga melanin: Ka taea e ia te whakataetae tika ki te tyrosine i roto i nga pūtau, te aukati i te hua o te mate o te tyrosine, me te whakaheke i te hanga melanin.
3. Aukati i te angiogenesis: Ka taea e ia te whakataetae tika ki te tyrosine i roto i nga pūtau, te aukati i te paanga catalytic o te tyrosine metabolism, me te aukati i te angiogenesis kiri. Ka taea e tenei te whakaiti i te maha o nga oko toto i roto me te huri noa i nga whiu chloasma, ka whakaiti i te puta o nga tauhohenga mumura, me te whakaiti i te hanganga tonu o te chloasma.
4.Ka taea e te waikawa tranexamic te whakaiti i te whakapuakitanga o nga cytokines pro-inflammatory me chemokines ki te whakaputa i nga paanga anti-inflammatory, ka taea te aukati i te puta o nga tauhohenga mate me te whakaiti i te hanganga o te hakihaki.
5. Ko te waikawa Tranexamic he taonga Anti-aging me te anti-photoaging. Ka whakanui ake i te whakahiato waikawa hyaluronic ma te whakanui ake i te maha o nga pūtau epidermal, ka whakaheke i te whakahekenga o te matrix extracellular i roto i nga dermis ma te aukati i te plasmin, a ka taea te whakaiti i nga taumata o etahi matū oxidative i roto i te toto hei whakapai ake i te tawhito o te kiri. Te whakapai ake i te whakaahua whakaahua a te UVB ma te whakanui ake i te biogenesis mitochondrial, te whakarite i te hunanga o te homoni ma te whakanui ake i te whakapuakitanga o nga kaiwhakawhiwhi o te estrogen i runga i te mata o nga pūtau mast, me te whakapai ake i te whakaahua whakaahua a UVA.
Waikawa Tranexamic Whakatakotoranga
Hebei WeiBang Biotechnology Co., Ltd
| Ingoa Hua | Te waikawa tranexamic | CAS No | 1197-18-8 |
| Te Ra Whakaputa | 2023/12/01 | Rā Pūrongo | 2023/12/01 |
| Te nui | 10,000KG | Te Ra Whakamatau | 2023/12/01 |
| PukaNo | WB20231201 | Te ora papa | 2 tau |
| Nga Tuemi Whakamatau | Whakatakotoranga | ||
| Te ahua | Te paura tioata ma | ||
| Tautuhinga | ME | ||
| Ngaronga i te whakamaroke | ≤0.50% | ||
| pH | 7.0-8.0 | ||
| Te whakamatautau | ≥99.0 | ||
| Te pungarehu ngongo | ≤0.10% | ||
| Matū whai pānga | poke A: ≤0.10% | ||
| poke B: ≤0.20% | |||
| Tetahi atu poke: ≤0.10% | |||
| Ko etahi atu poke katoa: ≤0.20% | |||
| pūhaumāota | ≤140ppm | ||
| Tatau pereti tapeke | ≤1000cfu/g | ||
| Te rewena me te pokepoke | ≤100cfu/g | ||
| Pb | ≤10mg/kg | ||
| As | ≤2mg/kg | ||
| Hg | ≤1mg/kg | ||
| Cd | ≤5mg/kg | ||
| Whakamutunga | Kua whai tohu | ||